Evidence map›Paper›PMID 37092550›Full record

ArticleJCI insight2023

β-Catenin signaling in alveolar macrophages enhances lung metastasis through a TNF-dependent mechanism.

Elliot D Kramer, Stephanie L Tzetzo, Sean H Colligan, Mary L Hensen, Craig M Brackett, Björn E Clausen, Makoto M Taketo, Scott I Abrams

Open access · goldAbstract read
In one paragraph

Article in JCI insight, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 18 papers.

0numbers the graph read from it
0cells of the map it votes in
18citing papers in PubMed
4.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

18 citing papers in PubMed, 28 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Review
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Review
  12. Article
  13. Article
  14. Review
  15. The roles of tissue resident macrophages in health and cancer.Experimental hematology & oncology · 2024
    Review
  16. Review
  17. Review
  18. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Elliot D KramerDepartment of Immunology and.
Stephanie L TzetzoDepartment of Immunology and.
Sean H ColliganDepartment of Immunology and.
Mary L HensenDepartment of Immunology and.
Craig M BrackettDepartment of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, New York, USA.
Björn E ClausenInstitute for Molecular Medicine, Paul Klein Center for Immune Intervention, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.
Makoto M TaketoDivision of Experimental Therapeutics, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Scott I AbramsDepartment of Immunology and.
Johannes Gutenberg University Mainz · DEKyoto University · JPRoswell Park Comprehensive Cancer Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MARK G FRATTINI · 1985 to 2026
$116.6M
Impact of Circulating Myeloid Cell Clusters on Anti-Tumor ImmunityR01CA250412 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI ABRAMS, SCOTT I., EVANS, SHARON S · 2021 to 2025
$3.4M
MULTIDISCIPLINARY APPROACHES TUMOR IMMUNOLOGYT32CA085183 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Scott I. Abrams · 2001 to 2026
$3.1M
Mechanisms Underlying Functional Programs of Tumor-Associated MacrophagesR01CA172105 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI ABRAMS, SCOTT I. · 2015 to 2019
$2.0M
Flow Cytometry SorterS10OD025183 · OD · ROSWELL PARK CANCER INSTITUTE CORP · PI WALLACE, PAUL K · 2018 to 2018
$318k
The Wnt-IRF8 axis: a Novel Regulator of Myeloid-Derived Suppressor Cell BiologyF30CA254327 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI KRAMER, ELLIOT DAVID · 2020 to 2023
$161k
Transcriptional Control of Macrophage-Mediated Mechanisms of MetastasisF31CA243304 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI TZETZO, STEPHANIE · 2019 to 2021
$91k
Regulation of IRF8 in PMN-MDSC Development Within the Bone Marrow MicroenvironmentF31CA228396 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI COLLIGAN, SEAN · 2018 to 2020
$89k
NCI NIH HHS F30 CA254327NCI NIH HHS F31 CA228396NCI NIH HHS F31 CA243304NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA172105NCI NIH HHS R01 CA250412NIH HHS S10 OD025183
6 · The paper itself

Abstract

The main cause of malignancy-related mortality is metastasis. Although metastatic progression is driven by diverse tumor-intrinsic mechanisms, there is a growing appreciation for the contribution of tumor-extrinsic elements of the tumor microenvironment, especially macrophages, which correlate with poor clinical outcomes. Macrophages consist of bone marrow-derived and tissue-resident populations. In contrast to bone marrow-derived macrophages, the transcriptional pathways that govern the pro-metastatic activities of tissue-resident macrophages (TRMs) remain less clear. Alveolar macrophages (AMs) are a TRM population with critical roles in tissue homeostasis and metastasis. Wnt/β-catenin signaling is a hallmark of cancer and has been identified as a pathologic regulator of AMs in infection. We tested the hypothesis that β-catenin expression in AMs enhances metastasis in solid tumor models. Using a genetic β-catenin gain-of-function approach, we demonstrated that (a) enhanced β-catenin in AMs heightened lung metastasis; (b) β-catenin activity in AMs drove a dysregulated inflammatory program strongly associated with Tnf expression; and (c) localized TNF-α blockade abrogated this metastatic outcome. Last, β-catenin gene CTNNB1 and TNF expression levels were positively correlated in AMs of patients with lung cancer. Overall, our findings revealed a Wnt/β-catenin/TNF-α pro-metastatic axis in AMs with potential therapeutic implications against tumors refractory to the antineoplastic actions of TNF-α.

Indexed as

Lung NeoplasmsMacrophages, Alveolarbeta CateninHumansTumor MicroenvironmentTumor Necrosis Factor-alphaWnt Signaling Pathwaybeta CateninTumor Necrosis Factor-alphaBreast cancerMacrophagesMouse modelsOncology

Identifiers

PMID37092550
PMCPMC10243816
OpenAlexW4366777481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.